RankAlpha logo
Back to Rankings

ADCT

ADC TherapeuticsA
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
ADCT vs peer average
95/100
ADCT vs. peer average (A vs. D)
Grade spread
B 1 · D 3 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IMDX is the first available peer comparator.

Same-sector, similar-market-cap screening candidate only; no direct operating or indication comparability was established, so it is excluded from valuation benchmarking.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerIMDXInsight Molecular Diagnostics
ADCT
ADC Therapeutics
IMDX
Insight Molecular Diagnostics
Grade
A
D
Momentum
8
12
Value
41
41
Sentiment
90
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs IMDX

ADCT / IMDX
Grade Position
Above peers
ADCT vs. peer average (A vs. D)
95/100
Momentum
8
IMDX
Value
41
ADCT
Sentiment
90
ADCT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ADCT
1
IMDX
IMDX
D
40/100
+3
2
MIST
MIST
D
40/100
+3
3
NGEN
NGEN
F
20/100
+4
4
QTRX
Quanterix Corp Common
F
20/100
+4
5
MXCT
MaxCyte Inc Common
F
20/100
+4
IMDX is the first peer returned for this comparison set.